Migraine & Headache

Beyond Headache Days: Migraine's Cognitive Toll Gets Closer Examination

Beyond Headache Days: Migraine's Cognitive Toll Gets Closer Examination

George Padron
Neurology & Mental Health, Migraine & Headache | Apr 23, 2026
Real-world INFUSE study data at AAN 2026 show eptinezumab improves migraine-related cognitive symptoms in over 50% of patients with prior anti-CGRP failure at 6 months.
Load More
Only Healthcare Today Covering Clinical Healthcare, Access and Cost

Only Healthcare Today
Covering Clinical Healthcare, Access and Cost

1 Hewitt Square, Suite 139
East Northport, NY 11731

Who We Are


About Us Editorial Policy Contributors & Partners

Connect


Contact Us Work With Us Advertising Terms of Use Privacy Policy